Transforming Contraception and Oncofertility with AMH Insights – SSR
The Society for the Study of Reproduction (SSR) shared a post on LinkedIn:
“We are thrilled to announce the upcoming Roger V. Short Lecture featuring David Pépin at Harvard Medical School and 2025 Medal Recipient.
While reproductive innovation has remained largely unchanged for decades, Dr. Pépin’s lab is unlocking the power of Anti-Müllerian Hormone (AMH) to transform:
Contraception: Developing non-hormonal, long-term alternatives (including gene therapy in felines!).
Oncofertility: Protecting the ovarian reserve and uterine integrity during chemotherapy.
Aging: Understanding how ‘follicle pausing’ can improve long-term women’s health.
- When: Friday, March 6, 2026
- Time: 4:00 PM – 5:00 PM
- Where: Zoom
Don’t miss this deep dive into the translational pipeline of ovarian biology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 13, 2026, 10:20Reproductive Outcomes for Same-Sex Couples Explored – JAMA
-
Feb 12, 2026, 15:16Exploring Expanded Carrier Screening for Pregnancy Health – Fertility and Sterility
-
Feb 12, 2026, 15:14Horace Roman: IFEM Endo Launches Masterclass for Endometriosis Surgeons in India
-
Feb 12, 2026, 15:12Nicolas Gatimel: Enhancing Reproductive Health Through Physical Activity
-
Feb 12, 2026, 15:10Adela Serban։ Elevate Your Gynecologic Ultrasound Skills in ART Procedures
-
Feb 12, 2026, 15:08Enhancing Fertility Awareness Through Community-Centered Initiatives – Fertility and Sterility
-
Feb 12, 2026, 14:11Discover Notable Papers in the Latest RBMO Digest Edition – RBMO
-
Feb 12, 2026, 13:18Christopher Robinson: Managing Impacted Fetal Head During Cesarean
-
Feb 12, 2026, 02:24Carrier Screening and Infertility Testing Through the Lens of GenEthics – ESHRE SIG Psychology and Counselling